SRF and atherosclerosis: Serum response factor (Srf), a master regulator of smooth muscle cell differentiation, was significantly downregulated, particularly in human atherosclerosis, along with its downstream effector Nexilin (Nexn), an actin filament–binding protein critical for cytoskeletal integrity [29].